- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Do | Roche to Acquire 89bio and Phase 3 MASH Candidate in Potential $3.5B Deal | ||
| Do | Kindeva Opens New UK HQ and Manufacturing Site | ||
| Mi | Cellares Selects Technology Providers to Expand Cell Q's Capabilities | ||
| Mi | Wheeler Bio to Support MindImmune's Alzheimer's Prevention Program | ||
| Mi | Mabwell Bioscience, Aditum Bio Form Kalexo Bio | ||
| Mi | GSK to Invest $30B in R&D and Manufacturing in the U.S. | ||
| Di | Lilly to Invest $5B in New Virginia Plant | ||
| Di | Parexel Taps Rob Goodwin as COO | ||
| Di | ProBioGen to Operate GMP Manufacturing Operation at Berlin Center for Gene & Cell Therapies | ||
| Di | CSL Enters Strategic Collaboration with VarmX for VMX-C001 | ||
| Di | Piramal Pharma Solutions Acquires Korsch XM-12 Bilayer Tablet Press | ||
| Di | Carolina Molecular, Astoriom Partner to Provide Molecular Testing & Biospecimen Storage Services | ||
| Di | GAIASO Appoints Tracey Brown Chief Executive Officer | ||
| Di | Takeda to Transport Products Between Europe and the U.S. with Sailing Cargo Vessels | ||
| 15.09. | Monte Rosa & Novartis Partner to Develop Immune-Mediated Disease Treatments | ||
| 15.09. | FUJIFILM Biosciences Introduces BalanCD HEK293 Perfusion A Medium | ||
| 15.09. | Thermo Fisher Scientific Launches Efficient-Pro Medium (+) Insulin | ||
| 15.09. | Chrysalis Taps Adam Bartley as Chief Operating Officer | ||
| 15.09. | Labcorp Completes Acquisition of BioReference Health Assets | ||
| 15.09. | Lonza Appoints Jason Berndt as Head of Group Operations | ||
| 15.09. | Corstasis Therapeutics' Enbumyst Gains FDA Approval | ||
| 15.09. | Abzena Introduces New GS Knockout Platforms | ||
| 15.09. | Avid Bioservices Appoints Kenneth Bilenberg as CEO | ||
| 12.09. | Alkermes Names Joshua Reed Chief Financial Officer | ||
| 12.09. | Precision BioSciences Presents Data from the Phase 1 ELIMINATE-B Trial |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .